Are you sure you want to exit?
Any unsave changes will be lost.
A2A Pharmaceuticals
Case Management
United States of America (USA), North America
2A Pharmaceuticals has designed selective covalent inhibitors of SARS-CoV-2 Main Protease
https://9414dbfe-e32e-4593-a92c-c68eaa2e81eb.filesusr.com/ugd/9e5253_308d0bf5a9ed46bbb9571d4cb9157f18.pdf